HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK’s OptiBiotix Offers GoFigure Prebiotic Range To Slim Down Saudi Arabia’s ‘Alarming’ Obesity Rates

Executive Summary

Thanks to a deal with local pharmacy chain Nahdi Medical, slimmers in the Kingdom of Saudi Arabia will soon be able to buy GoFigure shakes and bars, which contain OptiBiotix Health's trademarked SlimBiome prebiotic.

You may also be interested in...



UK’s OptiBiotix Launches Prebiotic Supplement Ingredient For European And African Markets

Dietary supplement manufacturers interested in marketing prebiotics and synbiotics – combinations of pre- and post-biotics – in Europe and Africa now have the option of OptiBiotix's xylo-oligosaccharide prebiotic, OptiXOS, which the firm claims has superior stability and gastrointestinal tolerance.

EFSA Considering New CBD Toxicity Data While Clock-Stop Causes Industry ‘Economic Harm’

The European Food Safety Authority is evaluating new reproductive and developmental toxicity data published since it paused CBD novel food applications last year due to safety concerns, according to food law consultancy, Legal Foods.

German OTC Launches: Bayer Adds Probiotics, Angelini Expands ThermaCare, And More

Two microbiome products added to Bayer's Iberogast line, a new drug-free pain-relieving ThermaCare knee brace from Angelini Pharma and an ashwagandha-powered sleep aid extension to Oyono from Klosterfrau feature in this German marketing update. 

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS153424

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel